/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Through insig hts derived from our scalable and proprietary Precision Psychiatry Platform, or our Platform, we aim to discover brain-based biomarkers to better identify which patients are more likely to respon…
$30.27
$0.71 (-2.29%)
EOD Sep 18, 2026
Negative free cash flow of -$52M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$84M
▼ -2.9% YoY
Op. Margin
—
ROIC
-34.26%
▲ +30.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$69M
▼ -4.6% YoY
Op. Cash Flow (TTM)
-$68M
▼ -9.2% YoY
Net Debt
-$223M
Net Cash Position
Cash & Equiv.
$244M
Continue Research
SourceComputed from the 10-Q filed 12 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 13 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.